AbCellera Biologics (ABCL) EBIT Growth (1y) (2021 - 2026)
AbCellera Biologics (ABCL) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
AbCellera Biologics |
1.55 Bn |
1.44 Bn |
- |
8.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
8.20% |
| Dec 31, 2025 |
60.71% |
| Sep 30, 2025 |
18.56% |
| Jun 30, 2025 |
46.94% |
| Mar 31, 2025 |
-14.15% |
| Dec 31, 2024 |
-10.15% |
| Sep 30, 2024 |
-70.64% |
| Jun 30, 2024 |
-81.86% |
| Mar 31, 2024 |
15.38% |
| Dec 31, 2023 |
-74.85% |
| Sep 30, 2023 |
-245.46% |
| Jun 30, 2023 |
-512.07% |
| Mar 31, 2023 |
-128.84% |
| Dec 31, 2022 |
-146.32% |
| Sep 30, 2022 |
234.31% |
| Jun 30, 2022 |
-19.38% |
| Mar 31, 2022 |
42.31% |
| Dec 31, 2021 |
-49.28% |
| Sep 30, 2021 |
-1,489.14% |
| Jun 30, 2021 |
-723.54% |
